These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2731977)

  • 21. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
    Kay RA; Ferguson A
    Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
    Savarino SJ; Hall ER; Bassily S; Wierzba TF; Youssef FG; Peruski LF; Abu-Elyazeed R; Rao M; Francis WM; El Mohamady H; Safwat M; Naficy AB; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD;
    Pediatr Infect Dis J; 2002 Apr; 21(4):322-30. PubMed ID: 12075764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
    Wu HY; Russell MW
    Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal antibody responses after immunisation with cholera B subunit.
    Svennerholm AM; Sack DA; Holmgren J; Bardhan PK
    Lancet; 1982 Feb; 1(8267):305-8. PubMed ID: 6120313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
    Pierce NF; Cray WC; Engel PF
    Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans.
    Jertborn M; Nordström I; Kilander A; Czerkinsky C; Holmgren J
    Infect Immun; 2001 Jun; 69(6):4125-8. PubMed ID: 11349086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of piglets against neonatal colibacillosis based on antitoxic immunity.
    Fürer E; Cryz SJ; Germanier R
    Dev Biol Stand; 1983; 53():161-7. PubMed ID: 6347760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease.
    Jertborn M; Svennerholm AM; Holmgren J
    Int Arch Allergy Appl Immunol; 1988; 85(3):358-63. PubMed ID: 3350611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
    Elson CO; Ealding W
    J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine.
    Qadri F; Ahmed T; Wahed MA; Ahmed F; Bhuiyan NA; Rahman AS; Clemens JD; Black RE; Albert MJ
    Vaccine; 2004 Jan; 22(3-4):416-21. PubMed ID: 14670323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
    Harokopakis E; Hajishengallis G; Michalek SM
    Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
    Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS; Dutta P; Dutta D; Ghose AC
    Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1992; 10(2):130-2. PubMed ID: 1539466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.